onr:"swepub:oai:DiVA.org:umu-147818"
Search: onr:"swepub:oai:DiVA.org:umu-147818" > Combining Polygenic...
- 1 of 1
- Previous record
- Next record
- To hitlist
Combining Polygenic Hazard Score With Volumetric MRI and Cognitive Measures Improves Prediction of Progression From Mild Cognitive Impairment to Alzheimer's Disease
-
- Kauppi, Karolina (author)
- Umeå universitet,Diagnostisk radiologi,Department of Radiology, University of California, San Diego, La Jolla, CA, United States
- Fan, Chun Chieh (author)
- McEvoy, Linda K. (author)
- show more...
- Holland, Dominic (author)
- Tan, Chin Hong (author)
- Chen, Chi-Hua (author)
- Andreassen, Ole A. (author)
- Desikan, Rahul S. (author)
- Dale, Anders M. (author)
- show less...
- (creator_code:org_t)
- 2018-04-30
- 2018
- English.
- In: Frontiers in Neuroscience. - : Frontiers Media S.A.. - 1662-4548 .- 1662-453X. ; 12
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Improved prediction of progression to Alzheimer's Disease (AD) among older individuals with mild cognitive impairment (MCI) is of high clinical and societal importance. We recently developed a polygenic hazard score (PHS) that predicted age of AD onset above and beyond APOE. Here, we used data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) to further explore the potential clinical utility of PHS for predicting AD development in older adults with MCI. We examined the predictive value of PHS alone and in combination with baseline structural magnetic resonance imaging (MRI) data on performance on the Mini-Mental State Exam (MMSE). In survival analyses, PHS significantly predicted time to progression from MCI to AD over 120 months (p = 1.07e-5), and PHS was significantly more predictive than APOE alone (p = 0.015). Combining PHS with baseline brain atrophy score and/or MMSE score significantly improved prediction compared to models without PHS (three-factor model p = 4.28e-17). Prediction model accuracies, sensitivities and area under the curve were also improved by including PHS in the model, compared to only using atrophy score and MMSE. Further, using linear mixed-effect modeling, PHS improved the prediction of change in the Clinical Dementia Rating—Sum of Boxes (CDR-SB) score and MMSE over 36 months in patients with MCI at baseline, beyond both APOE and baseline levels of brain atrophy. These results illustrate the potential clinical utility of PHS for assessment of risk for AD progression among individuals with MCI both alone, or in conjunction with clinical measures of prodromal disease including measures of cognitive function and regional brain atrophy.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Neurologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Neurology (hsv//eng)
Keyword
- pHs
- MCI
- AD prediction
- MRI
- genetics
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Frontiers in Neuroscience (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Kauppi, Karolina
- Fan, Chun Chieh
- McEvoy, Linda K.
- Holland, Dominic
- Tan, Chin Hong
- Chen, Chi-Hua
- show more...
- Andreassen, Ole ...
- Desikan, Rahul S ...
- Dale, Anders M.
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Neurology
- Articles in the publication
- Frontiers in Neu ...
- By the university
- Umeå University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
